VSV-Pseudovirus_Sudan Ebola Luciferase, ReVacc Scientific

Supplier: ReVacc Scientific

U95M81-200UL U95M81-1ML
76519-258EA 1017.08 CAD
76519-258 76519-260
VSV-Pseudovirus_Sudan Ebola Luciferase, ReVacc Scientific
Vectors, Plasmids and Libraries

This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry GP protein of Sudan ebolavirus strain (GenBank: KT878488.1).


Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See the titration result showing the undiluted pseudovirus generates signal over 100,000-fold higher than uninfected control (cell alone as background). The neutralizing activity of one published mAb called CA45 was tested by using this pseudotyped virus with a HIV control mAb.


As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Applications:
•Anti- Ebola neutralizing antibody screening at high throughput
•Anti- Ebola drug screening at high throughput
•Ebola pseudovirus transduction of target cells for viral entry and functional studies


See suggested protocol to use this product.


Accessories information: See suggested protocol to use this product.


Packaging: Shipping with dry ice. Require –80 °C storage. Multiple freeze/Thaw cycles will reduce its sensitivity. Recommend only 1 cycle. Aliquot after the first thaw.


Caution: Handle it in biosafety cabinet in BSL-2. Contacted tips and tubes should be decontaminated by 10% disinfecting bleach. For research use only.

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR